Skip to content
★ Sign in to follow
RS

Ravi S. Chari

Executive
HCA Healthcare, Inc.
Total declarations
61
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€6.1M

Latest filing published 26 Feb 2018 for HCA Healthcare, Inc..

Filing timeline

BuySale
Ravi S. Chari

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Ravi S. Chari: trading record in brief

Ravi S. Chari discloses dealings in HCA Healthcare, Inc. to SEC (Form 4). Between 5 February 2015 and 25 February 2018, the trades on record add up to 61 filings.

Every open-market trade on record is a sale: 6 sales worth €6.1M. Besides market trades, the filings include 26 share grants and 29 option exercises. Since January 2018: no purchases and 3 sales on the market.

The record was last updated on 26 February 2018 with a share grant in HCA Healthcare, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ravi S. Chari

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations60 total
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    8,800 shares0Common StockSEC:0001209191-18-013642:0
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    300 shares0Common StockSEC:0001209191-18-013642:1
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    930 sharesCommon StockSEC:0001209191-18-013642:3
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    316,802 USD11SEC
    3,151 shares@ US$100.542.4% of flowCommon StockSEC:0001209191-18-013642:2
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    22,891 USD11SEC
    227 shares@ US$100.840.2% of flowCommon StockSEC:0001209191-18-013642:4
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    500 sharesCommon StockSEC:0001209191-18-008287:0
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    14,288 USD11SEC
    149 shares@ US$95.890.1% of flowCommon StockSEC:0001209191-18-008287:1
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    142,214 USD11SEC
    3,825 shares@ US$37.181.0% of flowCommon StockSEC:0001209191-18-007219:0
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    151,106 USD11SEC
    3,150 shares@ US$47.971.1% of flowCommon StockSEC:0001209191-18-007219:1
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    189,640 USD11SEC
    2,750 shares@ US$68.961.4% of flowCommon StockSEC:0001209191-18-007219:2
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    356,598 USD11SEC
    5,125 shares@ US$69.582.6% of flowCommon StockSEC:0001209191-18-007219:3
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    1M USD12SEC
    9,937 shares@ US$101.167.4% of flowCommon StockSEC:0001209191-18-007219:4
  • ▼
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    58,555 USD29SEC
    568.05 shares@ US$103.080.4% of flowCommon StockSEC:0001209191-18-007219:5
  • ▼
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    1M USD30SEC
    10,000 shares@ US$101.507.5% of flowCommon StockSEC:0001209191-18-007219:6
  • ▼
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    581,661 USD29SEC
    5,702 shares@ US$102.014.3% of flowCommon StockSEC:0001209191-18-007219:7
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    38,254 USD11SEC
    6,397 shares@ US$5.980.3% of flowCommon StockSEC:0001209191-17-023543:0
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    18,837 USD11SEC
    1,184 shares@ US$15.910.2% of flowCommon StockSEC:0001209191-17-023543:1
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    324,938 USD11SEC
    18,750 shares@ US$17.332.7% of flowCommon StockSEC:0001209191-17-023543:2
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    66,719 USD11SEC
    3,125 shares@ US$21.350.6% of flowCommon StockSEC:0001209191-17-023543:3
  • ◇
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    55,250 USD11SEC
    2,500 shares@ US$22.100.5% of flowCommon StockSEC:0001209191-17-023543:4
  • ▼
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    3M USD25SEC
    31,956 shares@ US$90.0024.3% of flowCommon StockSEC:0001209191-17-023543:5
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    30,756 USD11SEC
    358 shares@ US$85.910.3% of flowCommon StockSEC:0001209191-17-014520:2
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    451 shares0Common StockSEC:0001209191-17-014520:0
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    0SEC
    400 shares0Common StockSEC:0001209191-17-014520:1
  • ◆
    SVP-Clinical ExcellenceExecutivesHCA Healthcare, Inc.
    17,598 USD11SEC
    210 shares@ US$83.800.1% of flowCommon StockSEC:0001209191-17-008459:1

25 of 60 declarations